The brains behind the BAD

Drs Belin and Ambrosio's Enhanced Ectasia module is a keratoconus index, based on pachy

The early detection of ectatic change is of paramount importance to the refractive surgeon. Anterior curvature and ultrasonic pachymetry, alone, does not provide enough information to detect early corneal disease. The combination of anterior and posterior elevation and complete pachymetric data gives the clinician a more complete view of the structure of the cornea and allows for more effective screening. The OCULUS Pentacam's Scheimpflug Cross-sectional imaging (OCULUS Optikgerate GmbH, Wetzlar, Germany) provides for a three-dimensional reconstruction of the anterior segment, making possible the assessment of the anterior and posterior corneal surfaces and the creation of a complete pachymetric map. The Belin / Ambrósio Enhanced Ectasia Display (BAD display) was designed to utilise the data supplied by the Pentacam's rotating Scheimpflug camera and provide a comprehensive keratoconus screening display. The display combines the anterior and posterior elevation and pachymetric data into one all-inclusive display giving the clinician a more complete overview of the corneal shape and allowing for quick and effective screening of refractive surgery patients.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Younger patients often require repeat corneal crosslinking, study finds
Utilising AAO cornea preferred practice patterns for corneal oedema, opacifications, ectasia and bacterial keratits
Investigating the effects of canaloplasty on corneal epithelium
Avoiding errors when converting to DMEK
EDOF lens tech is evolving to help more patients with intermediate vision
OC-01 (varenicline solution) investigated as possible treatment for dry eye symptoms, signs
Ill-timed corneal crosslinking led to permanent changes in corneal structure in patients with keratoconus
Investigating efficacy of OC-02 to stimulate the trigeminal nerve for the treatment of dry eyes
Corneal cross-linking and epithelial management: four pearls for success
Related Content
© 2023 MJH Life Sciences

All rights reserved.